Janus Henderson partners with American Cancer Society to support cancer research

The firm will donate half of its management fees from its Government Money Market fund

Doctor extracting samples with a pipette from a tray in a cancer research laboratory

|

Michael Nelson

Janus Henderson has teamed up with the American Cancer Society (ACS) to support its efforts in cancer research, advocacy and patient support.

Through this initiative, Janus Henderson will donate an amount equal to half of its management fees for all assets under management from its Government Money Market fund to ACS. The firm has committed to donating a minimum of $1m per year to ACS for the next three years through the partnership to support the fight against cancer.

“We are honoured to support the American Cancer Society, and it’s our sincere hope this partnership will help create a brighter future for many,” said Ali Dibadj, CEO of Janus Henderson.

“Among cancer’s many impacts, the financial burden of a diagnosis can be devastating. Through this initiative, Janus Henderson and our clients can now easily support ACS’ critical work in advocacy, research and patient support, helping to improve the lives of both cancer patients and their families.”

Cancer is one of the leading causes of death worldwide, and this year the annual ACS Cancer Facts & Figures report projects that the number of new cancer diagnoses in the United States will top two million. For many, access to quality care is not uniformly accessible and once diagnosed many may experience financial hardship.

“Together with Janus Henderson, we are supporting cancer patients and families across the cancer continuum by partnering in this innovative fundraising method,” said Dr Karen Knudsen, CEO of the American Cancer Society.

“Their generous support will increase our ability to fund groundbreaking research, advocate for better access to care at the federal and local levels and provide direct patient support to help us end cancer as we know it, for everyone.”